Dysport and Botox at a Ratio of 2.5:1 Units in Cervical Dystonia: A Double-Blind, Randomized Study

We aimed to compare Dysport (abobotulinumtoxinA, Ipsen Biopharm, Slough, UK) and Botox (onabotulinumtoxinA, Allergan, Irvine, CA, USA) at a 2.5:1 ratio in the treatment of cervical dystonia (CD). A Dysport/Botox ratio of lower than 3:1 was suggested as a more appropriate conversion ratio, considerin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Ji Young, Kim, Jae Woo, Kim, Hee-Tae, Chung, Sun Ju, Kim, Jong-Min, Cho, Jin Whan, Lee, Jee-Young, Lee, Ha Neul, You, Sooyeoun, Oh, Eungseok, Jeong, Heejeong, Kim, Young Eun, Kim, Han-Joon, Lee, Won Yong, Jeon, Beom S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359015/
https://www.ncbi.nlm.nih.gov/pubmed/25476727
http://dx.doi.org/10.1002/mds.26085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359015/
https://www.ncbi.nlm.nih.gov/pubmed/25476727
http://dx.doi.org/10.1002/mds.26085

Ejemplares similares